U.S. Mortgage Finance Stock News

NasdaqGS:FUNC 1 Year Share Price vs Fair Value Explore First United's Fair Values from the Community and select yours...

NasdaqCM:CISO 1 Year Share Price vs Fair Value Explore CISO Global's Fair Values from the Community and select yours...

NasdaqGS:SKYW 1 Year Share Price vs Fair Value Explore SkyWest's Fair Values from the Community and select yours We...

NYSE:ALV 1 Year Share Price vs Fair Value Explore Autoliv's Fair Values from the Community and select yours When close...

Maui Land & Pineapple Company ( NYSE:MLP ) Second Quarter 2025 Results Key Financial Results Revenue: US$4.60m (up 74...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Earlier this month, AvePoint reported second-quarter revenue of US$102.02 million, up from US$77.96 million a year ago, swinging to a net profit and raising its full-year financial guidance to US$406.6 million–US$410.6 million, representing 23%–24% annual growth expectations. Alongside these results, AvePoint launched a modernized Global Partner Program featuring engagement-based rewards and expanded technical resources, aiming to accelerate partner growth and deepen market reach in the...

Agree Realty Corporation recently announced that its Board of Directors declared a 2.4% increase in the monthly cash dividend for common shareholders, raising the annualized payout to US$3.072 per share and declared a preferred dividend as well, both payable in September 2025. This dividend increase signals management’s confidence in the company’s financial health and ongoing commitment to delivering steady shareholder returns. We'll explore how boosting the common dividend payout may...

Monster Beverage Corporation reported its second quarter 2025 earnings results, with sales rising to US$2.11 billion and net income reaching US$488.79 million, both higher than the same period last year. The company showed growth in both revenue and profitability for the quarter, while announcing no share repurchases during the reported period. To assess the implications on Monster's investment narrative, we'll examine how robust earnings growth highlights the company's progress amid global...

Earlier this month, PROCEPT BioRobotics Corporation reported its second-quarter and first-half 2025 earnings, highlighting sales growth to US$79.18 million for the quarter and a narrowing net loss of US$19.58 million compared to the previous year. The company also raised its full-year 2025 revenue guidance to approximately US$325.5 million, reflecting confidence in sustained sales momentum and operational improvements. We'll now consider how this raised full-year revenue guidance could...

Millicom International Cellular S.A. recently reported its second quarter 2025 results, posting net income of US$676 million and basic earnings per share of US$4.05, despite a year-over-year decrease in sales to US$1.37 billion. This substantial rise in profitability, coupled with the approval of an interim dividend of US$2.50 per share, points to enhanced operational efficiency and strong shareholder returns even as revenues decreased. We’ll explore how robust earnings growth, even...

Rivian Automotive recently reported its second quarter 2025 results, with revenue reaching US$1.30 billion and net loss decreasing to US$1.12 billion compared to the prior year. The reduction in net loss alongside revenue growth highlights Rivian's ongoing efforts to improve operational efficiency and cost management as it scales production. We'll examine how Rivian's narrowing losses this quarter inform its prospects for cost control and operational progress within the investment...

On August 14, 2025, Lufax Holding announced that Mr. Weidong Li resigned as independent non-executive director and key committee member, with Ms. Wai Ping Tina Lee appointed as his replacement to bolster board diversity in line with updated governance standards. Ms. Lee brings over four decades of legal and banking experience to the board at a time when regulatory changes are driving greater female representation in corporate leadership. We'll examine how the focus on enhanced board...

Hudson Pacific Properties, Inc. recently reported its second quarter and first half 2025 results, showing declines in both revenue and sales alongside wider net losses compared to the prior year, and updated its GAAP non-cash revenue guidance for the full year to a range of US$5.5 million to US$10.5 million. The updated guidance and financial results highlight continued operational and market headwinds, with year-over-year losses expanding despite efforts to manage costs and reposition the...

Axon Enterprise recently reported strong second quarter results, with revenue rising to US$668.54 million from US$503.24 million a year earlier, but net income declined compared to the prior year; it also raised its full-year 2025 revenue guidance to a new range of US$2.65 billion to US$2.73 billion. A key insight is that the company increased its annual revenue outlook following a period of significant sales growth, signaling sustained demand for its public safety solutions even as...

Protagonist Therapeutics recently reported its second quarter 2025 results, posting a net loss of US$34.77 million compared to US$30.62 million a year earlier, and announced a shelf registration statement allowing the potential sale of a range of securities in the future. The combination of a wider quarterly net loss and plans for possible future fundraising could signal a shift in the company's financial strategy and outlook. We’ll explore how the shelf registration announcement and...

National Health Investors, Inc. recently reported its second quarter 2025 results, showing increases in revenue and net income compared to the previous year, alongside an announced quarterly dividend of US$0.92 per share payable on October 31, 2025. Although sales and revenue advanced year over year, basic and diluted earnings per share from continuing operations slightly declined for the quarter, highlighting a shift in earnings allocation or cost structure. We'll take a closer look at how...

On August 6, 2025, Grand Canyon Education reported its second quarter and first half 2025 earnings, announcing net income of US$41.55 million for the quarter and US$113.16 million for the half year, along with higher basic and diluted earnings per share from continuing operations compared to the prior year. The company also raised its guidance for third and fourth quarter service revenue and diluted EPS, signaling stronger operational performance and confidence in its full-year outlook. We...

ReNew Energy Global Plc recently reported its first quarter FY26 results, recording INR41.18 billion in revenue and a net profit of INR5.13 billion, both showing significant year-over-year increases. The company's clean power capacity grew by 23% and ReNew surpassed analyst revenue estimates, while also reiterating guidance for continued capacity and operational expansion. We’ll explore how ReNew’s robust profit jump and clean energy capacity growth may shape the company’s longer-term...

National HealthCare Corporation recently reported its second quarter and six-month 2025 financial results, highlighting year-over-year revenue growth and confirming a quarterly dividend of US$0.64 per share for shareholders of record on September 30, 2025, payable on October 31, 2025. The combination of higher revenue and the continuation of regular dividend payments underscores the company’s commitment to returning value to shareholders despite a lower quarterly net income. We'll explore...

Earlier this month, Collegium Pharmaceutical reported a decrease in net income and earnings per share for the second quarter and first half of 2025 compared to the previous year, but raised its full-year net product revenue guidance and updated its buyback activity, including the repurchase of 692,281 shares for US$20.01 million during the last quarter. This combination of weaker earnings with increased revenue expectations and an ongoing share buyback program highlights a balancing act...

BeOne Medicines Ltd. recently reported second quarter 2025 earnings, showing revenue of US$1.32 billion and net income of US$94.32 million, marking a reversal from net losses in the previous year. The company also raised its full-year 2025 revenue guidance and now expects positive GAAP operating income, highlighting improved operational performance and momentum in its oncology business. We'll explore how BeOne's move to profitability and higher revenue guidance affect its investment...

AbCellera Biologics reported its second quarter and six-month earnings, showing quarterly revenue of US$17.08 million, more than doubling from a year ago, while six-month revenue reached US$21.32 million. Despite ongoing net losses, the strong revenue growth compared to the prior year signals business progress and could shift perceptions on the company’s operational momentum. We’ll examine how this recent revenue surge may affect the company’s outlook and the broader investment...

Travere Therapeutics recently announced its second quarter 2025 earnings, reporting revenue of US$114.45 million, compared to US$54.12 million for the same period last year, and a net loss of US$12.76 million versus US$70.41 million previously. This substantial year-over-year improvement in both revenue and net loss underscores the company's operational progress and strengthens its financial foundation. We'll explore how significant revenue gains and improved earnings performance influence...